Rodman & Renshaw Initiates Coverage On Alto Neuroscience With Buy Rating, Announces Price Target of $43
Rodman & Renshaw Initiates Coverage On Alto Neuroscience With Buy Rating, Announces Price Target of $43
羅德曼和倫肖授權對Alto Neuroscience進行買入評級，宣佈目標價爲43美元。
Rodman & Renshaw analyst Elemer Piros initiates coverage on Alto Neuroscience (NYSE:ANRO) with a Buy rating and announces Price Target of $43.
Rodman & Renshaw的分析師Elemer Piros發佈買入評級，並宣佈Alto Neuroscience（NYSE：ANRO）的目標價爲43美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。